TrialLung cancer (Amsterdam, Netherlands)2012

Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.

Nicholas P Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.